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Abstract
We report herein the case of a Belgian 76-year-old woman who
developed a hepatic tumour suspected to be a breast cancer metas-
tasis. Radiological imaging and guided biopsies were not contribu-
tive. The patient underwent an explorative laparoscopy with
frozen sections that did not provide further diagnosis, and an open
left bisegmentectomy was performed during the same anaesthesia.
Histopathological examination of the hepatic mass showed
Echinococcus multilocularis metacestodes, demonstrating alveolar
echinococcosis. As our patient denied any travel in foreign coun-
tries and has undergone regular abdominal ultrasonographies
since her mastectomy, it is highly likely that this alveolar
echinococcosis had been contracted in Belgium. If some imported
cases may be seldom managed in Belgium, to our knowledge, this
case is the first occurrence of alveolar echinococcosis contracted in
Belgium. This report, added to the demonstration of E. multilo-
caris infection of 50% of red foxes in Southern Belgium, and the
potential infection of domestic cats and dogs, should attract atten-
tion of the medical community on the possible outbreak of endem-
ic alveolar echinococcosis in Belgium, and on the related public
health concerns. (Acta gastroenterol. belg., 2002, 65, 55-60).
Key words : echinococcosis, zoonosis, liver, surgery, treatment,
pathology, case report, review.
Introduction
Alveolar echinococcosis is a parasitic disease related
to the development in the liver of cestodes larvae of
Echinococcus multilocularis, and must be differentiated
from the more common hydatid cyst, caused by Echino-
coccus granulosus. In this paper, we present a case of
alveolar echinococcosis that had been contracted in
Belgium. If some imported cases are seldom managed in
Belgium, to our knowledge, this case is the first occur-
rence of alveolar echinococcosis contracted in Belgium.
Case Report
The patient was a 76-year-old female living in the
Southern part of the province of Liège, with medical his-
tory including advanced rheumatoid polyarthritis con-
trolled by prednisolone 7.5 mg/day and methotrexate
7.5 mg/day, and breast cancer treated by right mastecto-
my in 1993. Since this operation, she had undergone
regular follow-up and yearly abdominal ultrasound. In
1998, an abdominal ultrasound detected a tumour in the
left liver lobe. Abdominal computed tomography (CT)
scanner confirmed a 7-cm large atypical mass in the left
liver, with irregular geographical border and a central
calcification (Fig. 1A). The diagnosis of metastasis was
suggested, and confirmed by the magnetic resonance
imaging (MRI) (Fig. 2). Liver blood tests showed normal
bilirubin level, normal transaminases, but cholestatic
enzymes were two fold the normal value. Tumour mar-
kers, including carcinoembryonic antigen, alpha-feto-
proetin and CA125, were negative. The positron emis-
sion tomography showed a large hypo-metabolic mass
in the left liver lobe, with a hyper-metabolic right border,
compatible with a necrotic tumour (Fig. 3). Two biopsies
of this liver mass were performed (Fig. 1B) but they only
provided amorphous necrotic material without cellular
analysable components. On March 24, 1999, the patient
underwent diagnostic laparoscopy (Fig. 4) with surgical
biopsies of the hepatic lesion, but frozen sections did not
reveal further relevant information. It was therefore
decided to performed an open left bisegmentectomy
(segments II and III) during the same anaesthesia.
Macroscopically the resected tissue showed a solitary
mass with a spongy aspect, microcystic like soft parts of
bread (Fig. 5) surrounded by a thick stringy veinstone
replacing the Glisson capsule. This lesion measured
10  8.5  5 cm and showed unclear nodular limits
extending into the residue of the parenchymatous tissue.
Many whitish nodules also raised the Glisson capsule.
Microscopically, these lesions corresponded to multiple
territories, with granulated surroundings of various
sizes, centred by a cystic cavity surrounded by a lami-
nine ringed membrane (Fig. 6), this one being empha-
sised by a thick histiocystoid crown comprising a few
giant cells. On various places, these cystic formations
had scolex head equipped with the characteristic hooks
of the E. multilocularis (Fig. 7). The residual hepatic
parenchyma showed important lesions of cholangitis
secondary to the biliary obstruction due to this lesion.
The postoperative course was uneventful and the
patient left the hospital at postoperative day 6. She had
been treated by albendazole 800 mg/day for six months.
At 1-year follow-up, she was asymptomatic and thoracic
and abdominal CT revealed no recurrence of the infec-
tious process. The patient owned a domestic dog that
could not tested for E. multilocaris because this animal
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died shortly before the diagnosis of liver alveolar
echinococcosis.
Discussion
Echinococcosis is a parasitic disease caused by the lar-
val (metacestode) stages of various cestodes (tapeworm)
species of the genus Echinococcus. Two of these para-
site species are of medical and public health importance
because they are widely prevalent and may cause severe
diseases in humans : (a) E. granulosus, that is the causal
agent of cystic echinococcosis, or cystic hydatid disea-
se ; (b) E. multilocularis, that causes alveolar echinococ-
cosis, or alveolar hydatid disease, in humans. Two other
species of the genus Echinococcus, namely, E. vogeli
and E. oligarthrus, are very rare in humans and may
cause so called polycystic echinococcosis (1). The four
species of Echinococcus are morphologically distinct in
their adult and metacestode stages, geographic distribu-
tion and host specificity. The first description of alveolar
hydatid disease is attributed to Buhl in 1852, under the
name “colloid alveolar cancer of the liver” (1). However,
it was Virchow in 1855 who recognised the parasite
nature of this disease and named it “Echinococcus ulcer-
ous tumour”. It is only in the 50’s that Rausch and
Schiller gave to one morphological parasite, different
from the E. granulosus, the pathogen causing alveolar
echinococcosis (2).
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Fig. 1. — Computed tomography of the liver showing a necrotic mass in the left liver lobe, with calcification. A biopsy of the mass
was performed (Fig. 1B).
Fig. 2. — Magnetic resonance imaging of the liver, confirming
the computed tomography.
Fig. 3. — Positron emission tomography demonstrating a large
hypo-metabolic mass in the left liver lobe (arrow), with a
hyper-metabolic right border.
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E. multilocularis seems to occur only in the Northern
Hemisphere. Four world sources are known : Central
Europe, (especially in Bavaria, from Tyrol extending to
Switzerland, in Eastern France, Austria and Germany),
North America (Alaska-Canada), Eurasia (Siberia and
Turkey) and China (1,2,3). In Belgium, no pure human
local case has ever been reported, to our knowledge.
However, in a study on foxes in Belgian Luxembourg
province in 1993 and 1995, it was shown that more than
50% of the foxes were E. multilocularis carriers (4).
This finding was also confirmed in the Netherlands (5).
It was also demonstrated that domestic cats and dogs
may be carriers and definite host for this parasite in
endemic regions (6), in urban regions (7) and in Belgium
(8). Therefore it seems likely that the rate of cases con-
tracted in Belgium may rise in the next future.
The adult E. multilocularis, whose life cycle is sum-
marised in the Figure 8, is a tapeworm measuring from
1 to 3 mm and has 3 to 6 segments. The anterior part is
composed of a rostrum with a double crown of hooks.
The last segment (mature or gravid proglottid) contains
an uterus full of ripe eggs. The adult lives attached to the
small intestine of the definitive host, mainly the red fox,
but dogs and cats are also vulnerable (Fig. 8) (6,7,8).
When the gravid proglottid arrives to maturity, it is
released in the faeces with 400 to 800 eggs. The eggs
contain the oncospheres, which have six hooks sur-
rounded by protective envelopes. The oncospheres are
resistant and remain infectious from 15 to 110 days,
depending on the outer conditions (2,9,10). The cycle
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Fig. 4. — Per-operative view of the diagnostic laparoscopy. The upper surface of the segments II and III showed white nodules
(Fig. 4A) that were also found at the lower surface (Fig. 4B).
Fig. 5. — Gross photography of the resected liver section,
showing a solid, white mass with spongy, microcystic aspect.
Fig. 6. — Pathology of the resected tissue (hematoxylin–eosin,
40 ) showing a cystic formation surrounded by a laminine
ringed membrane (a) and histocytoid, granulomatous
reaction (b).
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continues if field rodents (intermediate carriers) ingest
the eggs. Reaching the stomach of an intermediate host,
the oncospheres are released from their protective coat,
and by means of its larval hooks, penetrate the intestinal
wall, reaching the lamina propria within 30 to 120 min-
utes. The oncospheres migrate via the portal circulation
to the liver, where most are deposited. When the inter-
mediate host dies and his vital organs are devoured, each
consumed scolex may transform in an adult larva in the
small intestine of the definitive host. Human beings are
accidental intermediate hosts in this cycle, and may be
contaminated mainly by eating wild berries such as
wood strawberries, blackberries, blueberries soiled with
foxes excrements, or by contacts with contaminated
domestic animals (Fig. 8) (9). In humans, E. multilocu-
laris metacestodes are found almost exclusively in the
liver, but secondary lesions can form in the lung, brain,
and other organs (10).
There are differences in the development of cysts of
each of the various echinococcal species. In contrast to
the development of the unilocular hydatid cyst of E.
granulosus that grows slowly, about 1cm by 20 weeks,
the alveolar hydatid of E. multilocularis develops rapid-
ly with infiltrative and invasive abilities, characterised
by rapid dissemination to adjacent tissue. The germinal
layer of the metacestode proliferates both exogenously
and endogenously. This form of development and infil-
tration of the host tissue is facilitated by the relative
absence of pericyst and a very thin laminated layer. E.
multilocaris metacestodes invade liver tissue much like a
malignant tumour. The host response is variable. There
may be a granulomatous reaction or an extensive periph-
eral rim of necrosis, fibrosis and focal calcification. The
growth and the metastasis of hydatidosis in host tissues
are always associated with an intense humoral and cell-
mediated immune response. However, despite the per-
sistence of inflammatory responses during the entire
course of infection, the parasite grows in size until the
host dies. Although a fibrous reaction is characteristic of
the alveolar hydatic disease, there is no encapsulation by
the host to restrict the growth of the parasite. Thus, the
pronounced cell mediated responses are thought to be
due to a close intimacy between the parasite and the
host. This contrasts with E. granulosus infection in
which there is encapsulation creating a partial barrier
between parasite and host. Several mechanisms have
been considered to explain the ability of the parasite to
overcome the immune system of the host. With regard to
alveolar echinococcosis, most human patients develop
parasite-specific serum antibodies, including all types of
immunoglobulins (11). Very few patients fail to demon-
strate a humoral immune response (12). Antibodies are
thought to be involved in immunopathologic mecha-
nisms responsible for the occasional chronic granunulo-
matous course of the disease, including immune com-
plex associated membranous nephropathy and
histopathological changes related to the incidence of
amyloid and immune complex deposits in the liver, as
found in several patients. Parasitic- specific antibodies
alone are unable to control parasite growth, and host tis-
sue infiltration may be due partly to complement neu-
tralising factors released by the metacestode that cause
complement depletion at the host-parasite interface. In
vitro experiments have demonstrated the ability of pro-
toscolices of E. multilocularis to suppress murine T cell
function including the proliferation of CD-8 + T cells
while simultaneously inhibiting interleukin-2 (IL-2)
production and IL-2 receptor expression (13,14). In
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Fig. 7. — Pathology of the resected tissue (hematoxylin–eosin,
400 ) showing the histological aspect of E. multilocaris with
characteristic hooks (arrow).
Fig. 8. — Scheme of the E. multilocaris cycle
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humans, alveolar hydatidosis is also associated with
impaired T cell function by direct splenic T lymphocyte
cytotoxicity to the metacestode as measured by in vitro
assays and is characterised also by a decrease in total
peripheral lymphocytes and in circulating B lympho-
cytes percentage. Moreover, the state of the host
immune system influences probably the susceptibility to
the disease (15). In our patient receiving immunosup-
pressive drugs, one may suggest that this immunosup-
pression may have influenced the parasite development
and growth rate. 
In humans, the incubation period is estimated
between 5 and 15 years (16). Asymptomatic alveolar
echinococcosis may be detected by an unrelated ultra-
sound or CT (17). Symptoms are generally the result of
the enlarging hydatid disease on adjacent tissues and
organs and may mimic the symptoms of hepatic carci-
noma, cirrhosis, or other liver diseases (2,3). Jaundice
and hepatomegaly may be present. The obstructive jaun-
dice is most of the time incomplete and evolves in
thrusts. Sometimes angiocholitis may occur. Without
adapted therapy, the relapses are frequent, and the jaun-
dice becomes permanent leading to invalidating pruritus.
Usually the hepatomegaly is painless, but the palpation
shows an irregular surface with nodules comparable to a
metastatic liver. Compression of hepatic parenchyma
with portal hypertension may also occur (2,3). The gene-
ral state of health may be impaired, with asthenia,
anorexia, and loss of weight in a few weeks. The para-
sitic disease can spread to the peritoneum and the
abdominal organs, in particular to the spleen. Secondly,
it can “metastasise” into the lungs, the brain, the kid-
neys, or bones. Untreated alveolar hydatidosis is fatal
with 94% mortality within 10 years of diagnosis (2,3,). 
Immunodiagnostic (ELISA) tests are more reliable in
alveolar echinococcosis than in cystic echinococcosis,
with more than 95% of sensibility and specificity
(1,16,18,19). Radiological exams, either ultrasonogra-
phy, CT or magnetic resonance imaging, may demon-
strate the E. multilocaris lesions but are not very speci-
fic (17,20). The lesions are characterised by heteroge-
neous, hypodense masses, often associated with necrotic
cavities, by lack of a well-defined wall and by irregular
contours (16). Interestingly, calcifications within the
liver or at the periphery of lesions are characteristic fea-
tures of alveolar echinococosis and are present in 70%
of the cases (Fig. 1A) (16). Positron emission tomogra-
phy may show the metabolic activity of viable infection
of E. multilocaris, with hypometabolic regions corre-
sponding to necrosis, as in our case (Fig. 3). However,
the diagnostic power of positron emission tomography
and its role in the follow-up of these patients has still to
be assessed (21). Percutaneous fine needle aspiration
can be performed without risks of anaphylaxis or secon-
dary echinococcal infection but is usually non contribu-
tive due to fibrosis or necrosis. In most cases, as in ours,
the pathological exam of surgical specimen provides the
diagnosis. Surgical resection is the base of alveolar
echinococcosis management (22,23). Without radical
removal, the lesions inevitably spread out with compli-
cated infections (angiocholitis, hepatic abscess) or
mechanical complications (portal high blood pressure,
spontaneous fistula) (22). After surgical resection anti
parasite drugs are required. Many studies proved the
efficiency of benzimidazole derivatives in reducing the
size of the lesions and in improving of the clinical symp-
toms (24,25). Albendazole (10 -15 mg/kg/day) should
be administrated during 6 to 12 months or more after the
procedure. The non resectable lesions should be medi-
cally treated during a longer period (24). Liver trans-
plantation may be a life-saving palliative measure in
patients with non resectable hepatic lesions (26,27).
Unfortunately, growth of residual parasitic tissue may be
enhanced by the immunosuppressive therapy given to
the transplant recipient (15), and recurrences after liver
transplantation are not infrequent (28). Radiological and
serological surveillance must be continued indefinitely
to monitor for recurrence and/or progression of disease.
In conclusion, we report herein the first published
case of alveolar echinoccocosis contracted in Belgium.
This report, added to the demonstration of the presence
of E. multilocaris infection in more than 50% of red
foxes in Southern Belgium, and the potential infection
of domestic cats and dogs, should attract attention of the
medical community regarding the possible outbreak of
endemic alveolar echinococcosis in Belgium, and the
related public health concerns.
References
1. GOTTSTEIN B. Molecular and immunological diagnosis of echinococcosis.
Clin. Microbiol. Rev., 1992, 5 : 248-261.
2. GOLVAN Y.L . Les échinoccocoses. In : FLAMMARION (ed). Eléments de
parasitologie médicale. Paris, France, 1978 : 123-145.
3. KAMMERER W.S., SCHANTZ P.M. Ecchinococcal disease. Infect. Dis.
Clin. North Am., 1993, 7 : 605-618.
4. LOSSON B.J., MIGNON B., BROCHIER B., BAUDUIN B., PASTORET P.
Infestation du renard roux (Vulpes vulpes) par Echinococcus multilocularis
dans la province de Luxembourg (Belgique) : résultats de l’enquête effectuée
entre, 1993 et, 1995. Ann. Med. Vet., 1997, 141 : 149-153,.
5. VAN DER GIESSEN J.W., ROMBOUT Y.B., FRANCHIMONT J.H.,
LIMPER L.P., HOMAN W.L. Detection of Echinococcus multilocularis in
foxes in The Netherlands. Vet. Parasitol., 1999, 82 : 49-57.
6. PETAVY A.F., TENORA F., DEBLOCK S., SERGENT V. Echinococcus
multilocaris in domestic cats in France. A potential risk factor for alveolar
hydatid disease contamination in humans. Vet. Parasitol., 2000, 87 : 151-
156.
7. PETAVY A.F., PROST C., GEVREY J., GILOT B., DEBLOCK S. Infesta-
tion naturelle du chat domestique (Felis catus L.) par Echinococcus multi-
locularis Leuckaert, 1863 (Cestoda) : premier cas en France décelé en zone
périurbaine. C. R. Acad. Sci. III, 1988, 307 : 553-556.
8. LOSSON B.J., COIGNOUL F. Larval Echinococcus multilocaris infection
in a dog. Vet. Rec., 1997, 141 : 49-50.
9. PETAVY A.F. Life cycles of Echinococcus multilocularis in relation to
human infection. J. Parasitol., 1991, 77 : 133-137.
10. BHATIA G. Echinococcus. Semin. Respir. Infect., 1997, 12 : 171-187.
11. PLAYFORD M.C., KAMIYA M. Immune response to Echinococcus multi-
locaris infection in the mouse mode : a review. Jpn. J. Vet. Res., 1992, 40 :
113-130.
12. GOTTSTEIN B., MESARINA B., TANNER I., AMMANN R.W.,
WILSON J.F., ECKERT J., LANIER A. Specific cellular and humoral
immune responses in patients with different long-term courses of alveolar
echinococcosis (infection with Echinococcus multilocaris). Am. J. Trop.
Med. Hyg., 1991, 45 : 734-742.
Acta Gastro-Enterologica Belgica, Vol. LXV, January-March 2002
60 K. Delbecque et al.
13. ALKARMI T, BEHBEHANI K. Echinococcus multilocaris : inhibition of
murine neutrophil and macrophage chemotaxis. Exp. Parasitol., 1989, 69 :
16-22.
14. BRESSON-HADNI S., VUITTON D.A., LENYS D., LIANCE M.,
RACADOT E., MIGUET J.P. Cellular immune response in Echinococcosis
multilocaris infection in human. I. Lymphocyte reactivity to Echinococcus
antigens in patients with alveolar echinococcosis. Clin. Exp. Immunol.,
1989, 78 : 61-66.
15. LIANCE M., BRESSON-HADNI S., VUITTON DA., LENYS D., CAR-
BILLET J.P., HOUIN R. Effects of cyclosporin A on the course of murine
alveolar echinococcosis and on specific cellular and humoral immune
response against Echinococcus multilocaris. Int. J. Parasitol., 1992, 22 :
213-28.
16. AMMAM R.W., ECKERT J. Cestodes. Echinococcus. Gastroenterol. Clin.
North Am., 1996, 25 : 655-689.
17. CHOJI K., FUJITA N., CHEN M., SPIERS A.S., MORITA Y.,
SHINOHARA M., NOJIMA T., IRIE G. Alveolar hydatid disease of the
liver : computed tomography and transabdominal ultrasound with histo-
pathological correlation. Clin. Radiol., 1992, 46 : 97-103.
18. GOTTSTEIN B., SCHANTZ P.M., WILSON J.F. Serologic screening for
Echinococcosus multilocularis infections with ELISA. Lancet, 1985, 8437 :
1097-1098.
19. LANIER A.P., TRUJILLO D.E., SCHANTZ P.M., WILSON J.F.,
GOTTSTEIN B., MC MAHON B.J. Comparison of serologic tests for diag-
nosis and follow up of alveolar hydatid disease. Am. J. Trop. Med. Hyg.,
1987, 37 : 609-615.
20. BALCI N.C., TUNACI A., SEMELKA R.C., TUNACI M., OZDEN I.,
ROZANES I., ACUNAS B. Hepatic alveolar echinococcosis : MRI findings.
Magn. Reson. Imaging, 2000, 18 : 537-541.
21. REUTER S., SCHIRRMEISTER H., KRATZER W., DREWECK C.,
RESKE S.N., KERN P. Pericystic metabolic activity in alveolar echinococ-
cosis : assessment and follow-up by positron emission tomography. Clin.
Infect. Dis., 1999, 29 : 1157-1163.
22. GOLLACKNER B., LANGLE F., AUER H., MAIER A., MITTLBOCK M.,
AGSTNER I., KARNER J., LANGER F., ASPOCK H., LOIDOLT H.,
ROCKENSCHAUB S., STEININGER R. Radical surgical therapy of
abdominal cystic hydatid disease : factors of recurrence. World J. Surg.,
2000, 24 : 717-721.
23. BALIK A.A., BASOGLU M., CELEBI F., OREN D., POLAT K.Y., ATA-
MANALP S.S., AKCAY M.N. Surgical treatment of hydatid disease of the
liver : review of 304 cases. Arch. Surg., 1999, 134 : 166-169.
24. AMMANN R.W., ILITSCH N., MARINCEK B., FREIBURGHAUS A.U.
and the Swiss echinococcosis study group. Effect of chemotherapy on the
larval mass and the long-term course of alveolar echinococcosis.
Hepatology, 1993, 19 : 735-742.
25. ISHUZU H., UCHINO J., SATO N., AOKI S., SUZUKI K., KURIBAYASHI
H. Effect of albendazole on recurrent and residual alveolar echinococcosis of
the liver after surgery. Hepatology, 1997, 25 : 528-531.
26. BRESSON-HADNI S., FRANZA A., MIGUET J.P., VUITTON D.A.,
LENYS D., MONNET E., LANDECY G., PAINTAUD G., ROHMER P.,
BECKER M.C. Orthotopic liver transplantation for incurable alveolar
echinococcosis of the liver : report of 17 cases. Hepatology, 1991, 13 : 1061-
1070.
27. MBOTI B., VAN DE STADT J., CARLIER Y., PENY M., JACOBS F.,
BOURGEOIS N., ADLER M., GELIN M. Long-term disease-free survival
after liver transplantation for alveolar echinococcosis. Acta Chir. Belg.,
1996, 96 : 229-232.
28. BRESSON-HADNI S., KOCH S., BEURTON I., VUITTON D.A.,
BARTHOLOMOT B., HRUSOVSKY S., HEYD B., LENYS D., MINELLO
A., BECKER M.C., VANLEMMENS C., MANTION G.A., MIGUET J.P.
Primary disease recurrence after liver transplantation for alveolar echinococ-
cosis : long-term evaluation in 15 patients. Hepatology, 1999, 30 : 857-864.
Acta Gastro-Enterologica Belgica, Vol. LXV, January-March 2002
